DGAP-News: Celesio AG / Key word(s): Quarter Results
Celesio AG: Celesio increases operating earnings and concludes
divestment programme
14.11.2012 / 07:00
---------------------------------------------------------------------
Key figures of the Celesio Group
1st-3rd quarter 1st-3rd quarter
2011 2012
Continued
operations
Revenue EUR m 16,511.1 16,696.8
EBITDA EUR m 397.0 382.6
adjusted 1) 3) EUR m 397.0 430.1
EBIT EUR m 261.4 269.7
adjusted 1)3) EUR m 305.7 329.6
Net profit/loss EUR m 102.1 72.2
adjusted 1) 3)4)5) EUR m 146.5 160.2
Retail pharmacies 6) 2,298 2,232
Wholesale
branches 6) 133 141
Discontinued
operations
Net profit/loss EUR m -72.4 -262.7
Continued and
discontinued
operations
Employees
(headcount) 6) 46,667 41,015
Net profit/loss EUR m 29.7 -190.5
Change Change
on a adjusted for
euro basis portfolio and
currency
effects 2)
% %
Revenue EUR m 1.1 -1.7
EBITDA EUR m -3.6 -4.6
adjusted 1) 3) EUR m 8.3 0.5
EBIT EUR m 3.2 -11.7
adjusted 1)3) EUR m 7.8 -1.3
Net profit/loss EUR m -29.3 ---
adjusted 1) 3)4)5) EUR m 9.4 ---
Discontinued
operations
Net profit/loss EUR m >=100 ---
Continued and
discontinued
operations
Net profit/loss EUR m --- ---
1) Adjusted for non-recurring effects (including tax effect) primarily in
connection with the Operational Excellence Programme
2) The change adjusted for portfolio and currency effects (organic growth)
eliminates the effects of currency translation, consolidated group changes
(elimination of all units that were not already consolidated as of 1
January of the previous year), gains/losses on disposal and impairment
losses on intangible assets
3) Adjusted for special effects from remeasurements pursuant to IFRS 5
(including tax effect)
4) Adjusted for impairment losses recognised on intangible assets
(including tax effect)
5) Adjusted for special effects, which are included in the financial result
(including tax effect)
6) Closing figures at the end of the reporting period
Press contact
Dr Jens Schreiber, Celesio AG, +49 (0)711.5001-380
media@celesio.com
Rainer Berghausen, Celesio AG, +49 (0)711.5001-549
media@celesio.com
About Celesio Group
As a leading international trading company and provider of logistics and
services in the pharmaceutical and healthcare sector, Celesio takes a
proactive and preventive approach to ensuring that patients receive the
products and support that they require for optimum care. We operate in 18
countries around the world and have about 41,000 employees. Every day, we
serve over 2 million customers - at 2,200 pharmacies of our own and 4,500
participants in our brand partnership schemes. With around 140 wholesale
branches, we supply approximately 65,000 pharmacies and hospitals every day
with up to 130,000 pharmaceutical products. Our services benefit a patient
pool of about 15 million per day.
End of Corporate News
---------------------------------------------------------------------
14.11.2012 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: Celesio AG
Neckartalstr. 155
70376 Stuttgart
Germany
Phone: +49 (0)711 5001-735
Fax: +49 (0)711 5001-740
E-mail: investor@celesio.com
Internet: www.celesio.com
ISIN: DE000CLS1001
WKN: CLS100
Indices: MDAX
Listed: Regulierter Markt in Berlin, Düsseldorf, Frankfurt (Prime
Standard), München, Stuttgart; Freiverkehr in Hamburg,
Hannover; Terminbörse EUREX
End of News DGAP News-Service
---------------------------------------------------------------------
193101 14.11.2012
DGAP-News: Celesio AG: Celesio increases operating earnings and concludes divestment programme
| Source: EQS Group AG